ArticleFrontiers in immunology2021

Tofacitinib Ameliorates Lupus Through Suppression of T Cell Activation Mediated by TGF-Beta Type I Receptor.

Qing Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.